MIT Sloan logo MIT logo

Research



to


Was the Role of the Fed as the Last Instance Lender Downplayed in 2008? Or Just Forgot?

Coronavirus Vaccine Race Stirs $200 Billion Market Bubble

How Often Do Vaccine Trials Hit Paydirt?

NPO Investing: Bigger Funds, Bigger Risks, Bigger Returns

The Drug Dreams Cause Euphoria

5 Ways The World Fought Back

What Drives Outperformance at Endowments & Foundations

Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

Vaccines More Likely To Get Through Clinical Trials Than Other Types Of Drugs, MIT Study Finds

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | ...38 |